152 related articles for article (PubMed ID: 4365124)
21. Retrospective study on the evaluation of diagnostic procedure for hepatoma in patients with cirrhosis of the liver.
Kawata H; Shimizu Y; Kojima G; Taniguchi T; Nishiyama S
Acta Hepatogastroenterol (Stuttg); 1974 Apr; 21(2):106-19. PubMed ID: 4375388
[No Abstract] [Full Text] [Related]
22. Primary liver cell carcinoma and post-necrotic cirrhosis associated with Australia antigen and alpha-feto protein. (A case report).
Malaviya AN; Nayak NC
J Assoc Physicians India; 1971 Oct; 19(10):697-700. PubMed ID: 4332064
[No Abstract] [Full Text] [Related]
23. Serum gamma-globulins and hepatitis-associated antigen in blood donors, chronic liver disease and primary hepatoma.
Hirayama C; Tominaga K; Irisa T; Nakamura M
Digestion; 1972; 7(5):257-65. PubMed ID: 4135905
[No Abstract] [Full Text] [Related]
24. Demonstration of alpha-Fetoglobulin in hepatoma tissue by fluorescent antibody technique.
Chu ML; Lin WS; Yoshida TO; Chu SH; Lin TY
Cancer; 1974 Aug; 34(2):268-73. PubMed ID: 4368565
[No Abstract] [Full Text] [Related]
25. [Hepatoma in cirrhosis. Serum alpha-feto-protein levels after hepatic dearterialization].
Huguier M; Hirsch-Marie H
Nouv Presse Med; 1972 Dec; 1(43):2905-6. PubMed ID: 4346284
[No Abstract] [Full Text] [Related]
26. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
27. Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver.
Ruoslahti E; Seppälä M; Vuopio P; Saksela E; Peltokallio P
J Natl Cancer Inst; 1972 Sep; 49(3):623-30. PubMed ID: 4345964
[No Abstract] [Full Text] [Related]
28. Immunodiagnosis of a metastasis in a patient with a history of double malignant disease.
Gardner MA; Maluish A; Halliday WJ; Clunie GJ
Med J Aust; 1975 Apr; 1(14):446-8. PubMed ID: 1160704
[TBL] [Abstract][Full Text] [Related]
29. [Hepatitis B antigen in the serum in chronic liver diseases and malignant hepatoma].
Libman E; Stojsić S; Marton B; Lemberger J
Med Pregl; 1981; 34(9-10):389-92. PubMed ID: 6281636
[No Abstract] [Full Text] [Related]
30. Studies on cell-mediated immunity in patients with colorectal cancer: leucocyte migration inhibition test using allogenic 3M KCl extract.
Kojima O; Fujita Y; Iwai N; Yamane T; Kitagawa N; Nishioka B; Majima S
Aust N Z J Surg; 1981 Oct; 51(5):434-9. PubMed ID: 6947781
[TBL] [Abstract][Full Text] [Related]
31. Early detection of hepatoma: prospective study in liver cirrhosis using passive hemagglutination and the radioimmunoassay.
Lehmann FG
Ann N Y Acad Sci; 1975 Aug; 259():196-210. PubMed ID: 54021
[TBL] [Abstract][Full Text] [Related]
32. Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma.
Halliday WJ; Maluish AE; Little JH; Davis NC
Int J Cancer; 1975 Oct; 16(4):645-58. PubMed ID: 51836
[TBL] [Abstract][Full Text] [Related]
33. Proceedings: Serum alpha-fetoprotein and Ga67 citrate uptake in hepatoma.
Suzuki T; Matsumoto Y; Manabe T; Honjo I; Hamamoto K
Am J Roentgenol Radium Ther Nucl Med; 1974 Mar; 120(3):627-33. PubMed ID: 4361385
[No Abstract] [Full Text] [Related]
34. Alpha-Fetoprotein and hepatitis B antigen in hepatocarcinogenesis.
Sakurai M; Miyaji T
Ann N Y Acad Sci; 1975 Aug; 259():156-67. PubMed ID: 54018
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis-associated antigen and hepatocellular carcinoma in Taiwan.
Tong MJ; Sun SC; Schaeffer BT; Chang NK; Lo KJ; Peters RL
Ann Intern Med; 1971 Nov; 75(5):687-91. PubMed ID: 4330676
[No Abstract] [Full Text] [Related]
36. Clinical observations during a relatively early stage of hepatocellular carcinoma, with special reference to serum alpha-fetoprotein levels.
Okuda K; Kotoda K; Obata H; Hayashi N; Hisamitsu T
Gastroenterology; 1975 Jul; 69(1):226-34. PubMed ID: 50251
[TBL] [Abstract][Full Text] [Related]
37. [Detection of -fetoprotein and its clinical significance].
Ishii M; Inoue E; Tozawa T; Ikehara H; Baba S
Nihon Rinsho; 1972 May; 30(5):1220-9. PubMed ID: 4339910
[No Abstract] [Full Text] [Related]
38. Inhibition of leukocyte migration by tumor-associated antigen in soluble extracts of human hepatoma.
Lee C; Chen S; Lin T
Cancer Res; 1977 Mar; 37(3):918-21. PubMed ID: 189919
[TBL] [Abstract][Full Text] [Related]
39. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathological examination of -fetoprotein and hepatoma].
Kasai Y; Mito M; Miyakawa A; Sasaki K
Nihon Rinsho; 1972 May; 30(5):1186-93. PubMed ID: 4339906
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
